EU Talks With Pfizer, Sanofi, J&J on Coronavirus Vaccines Hit Snags Over Pricing: Report
4 years, 8 months ago

EU Talks With Pfizer, Sanofi, J&J on Coronavirus Vaccines Hit Snags Over Pricing: Report

News 18  

European efforts to secure potential COVID-19 vaccines from Pfizer, Sanofi and Johnson & Johnson are mired in wrangles over price, payment method and potential liability costs, three EU officials told Reuters. The EU's negotiations with Johnson & Johnson are among the most advanced but have yet to conclude amid a back-and-forth over how to share liability costs if the potential vaccine showed unexpected side-effects, two of the officials told Reuters. France's Sanofi is negotiating to supply 300 million doses of the potential vaccine it is developing with British drugmaker GlaxoSmithKline Plc to the EU and wants an immediate upfront payment for the entire stock, two officials said. Aside from the Pfizer, Sanofi and Johnson & Johnson discussions, the EU is also in talks with biotech companies Moderna and Germany's CureVac, officials told Reuters earlier in July.

Potential Officials Johnson Talks Million Told Reuters Vaccine Moderna Sanofi Pfizer Biontech Curevac  hit  pricing  officials  pfizer  jj  vaccines  million  potential  talks  snags  report  vaccine  johnson  sanofi  told  eu

History of this topic

EU countries destroyed €4 billion worth of Covid-19 vaccines, reveals research
1 year, 3 months ago

EU countries destroyed €4 billion worth of Covid-19 vaccines, reveals research

Firstpost  

Governments, including the EU’s second-most populous country France, have been reluctant to reveal the scale of the waste, but it is certain that most EU nations have resorted to wasting doses of the Covid-19 vaccine, once a much sought after commodity Nearly 215 million doses of Covid-19 vaccines purchased by EU countries at the height of the pandemic have since …

COVID-19 treatments to enter the market with a hefty price tag
1 year, 5 months ago

COVID-19 treatments to enter the market with a hefty price tag

The Independent  

For free real time breaking news alerts sent straight to your inbox sign up to our breaking news emails Sign up to our free breaking news emails Please enter a valid email address Please enter a valid email address SIGN UP I would like to be emailed about offers, events and updates from The Independent. Please try again later {{ …

COVID-19 treatments to enter the market with a hefty price tag
1 year, 5 months ago

COVID-19 treatments to enter the market with a hefty price tag

Associated Press  

WASHINGTON — The COVID-19 treatments millions of Americans have taken for free from the federal government will enter the private market next week with a hefty price tag. The less commonly used COVID-19 treatment Lagevrio, manufactured by Merck, also will hit the market next week. “Pfizer is committed to a smooth commercial transition and is working collaboratively with the U.S. …

Pfizer boss claims Covid shot will remain 'free for all Americans' - despite marking up shot 10,000%
2 years, 4 months ago

Pfizer boss claims Covid shot will remain 'free for all Americans' - despite marking up shot 10,000%

Daily Mail  

Pfizer CEO Albert Bourla is under fire after claiming his firm's Covid vaccine will remain ‘free for all Americans’ – despite plans for a massive price hike. That marks a 10,000 per cent mark up from the estimated $1.18 it costs the New York City-based company to produce each dose of the vaccine. David Denton told investors in an earnings …

Pfizer to offer low-cost medicines, vaccines to poor nations
2 years, 10 months ago

Pfizer to offer low-cost medicines, vaccines to poor nations

Associated Press  

Pfizer said Wednesday that it will provide nearly two dozen products, including its top-selling COVID-19 vaccine and treatment, at not-for-profit prices in some of the world’s poorest countries. The drugmaker announced the program at the World Economic Forum’s annual gathering in Davos, Switzerland, and said it was aimed at improving health equity in 45 lower-income countries. “What we discovered through …

EU ombudsman slams executive arm over vaccine communication
3 years, 2 months ago

EU ombudsman slams executive arm over vaccine communication

Associated Press  

BRUSSELS — The European Union’s executive arm is responsible of “maladministration” for mishandling a request for access to text messages between its president and the CEO of pharmaceutical company Pfizer regarding COVID-19 vaccine purchases, the bloc’s ombudsman said Friday. In April last year, a story published by the New York Times revealed that EU Commission President Ursula von der Leyen …

Pfizer, Moderna to raise prices for Europe: Report
3 years, 7 months ago

Pfizer, Moderna to raise prices for Europe: Report

Al Jazeera  

Europe is keen to shore up protection and curb the spread of the more transmissible Delta variant. The new price for the Pfizer shot was 19.50 euros compared with 15.50 euros previously, the media outlet said, citing portions of the contracts it had seen. The price of a dose of the Moderna vaccine was set at $25.50, according to the …

India Close to Giving Indemnity to Foreign Vaccine Makers Like Pfizer: Report
3 years, 9 months ago

India Close to Giving Indemnity to Foreign Vaccine Makers Like Pfizer: Report

News 18  

India is close to agreeing to grant foreign COVID-19 vaccine makers such as Pfizer Inc protection against legal liability so that it can use their shots in an immunisation campaign that is facing acute shortages, three government sources told Reuters. India has not granted indemnity to any COVID-19 vaccine maker, but the sources, who requested anonymity, said the government was …

EU signs new deal with Pfizer-BioNTech, Hungary opts out
3 years, 10 months ago

EU signs new deal with Pfizer-BioNTech, Hungary opts out

Associated Press  

BRUSSELS — The European Union’s executive arm on Thursday finalized a third vaccine contract with Pfizer and BioNTech through 2023 for an additional 1.8 billion doses of their COVID-19 shot to share between the bloc’s countries except for Hungary, which opted out of the deal. The European commission said the contract, which was agreed on behalf of all 27 EU …

Pfizer’s Reckless Policy on Allocation & Pricing of COVID-19 Vaccine Endangers the World
3 years, 10 months ago

Pfizer’s Reckless Policy on Allocation & Pricing of COVID-19 Vaccine Endangers the World

News 18  

Pandemics, like wildfires, need to be extinguished quickly, otherwise they spiral out of control. Pfizer’s policies in regard to the allocation and pricing of its COVID-19 vaccine have brought the developing world to the brink of an enormous humanitarian catastrophe and has exposed rich countries to serious risks in the time to come. Recognising this, the World Health Organisation, in …

EU Seals Deal for Extra 1.8 Billion BioNTech-Pfizer Covid-19 Vaccine Doses
3 years, 10 months ago

EU Seals Deal for Extra 1.8 Billion BioNTech-Pfizer Covid-19 Vaccine Doses

News 18  

The EU has concluded a deal with BioNTech/Pfizer for up to 1.8 billion extra doses of their Covid-19 vaccine, European Commission chief Ursula von der Leyen said on Saturday. The contract, on top of the 600 million BioNTech/Pfizer doses the commission has already secured, aims to supply the bloc — population 450 million — with enough jabs for booster shots, …

Pfizer’s posts $4.9B 1Q profit as vaccine strategy pays off
3 years, 10 months ago

Pfizer’s posts $4.9B 1Q profit as vaccine strategy pays off

Associated Press  

Selling vaccines during a pandemic has boosted Pfizer’s bottom line and proven that a strategy it embarked upon over a decade ago is now paying off handsomely. The New York-based pharmaceutical giant reported Tuesday that it earned $4.9 billion in the first three months of the year and it dramatically raised its profit forecast for all of 2021 thanks to …

European Union sues AstraZeneca over COVID vaccine delays
3 years, 11 months ago

European Union sues AstraZeneca over COVID vaccine delays

ABC  

The European Commission has launched legal action against AstraZeneca for not respecting its contract for the supply of COVID-19 vaccines and for not having a "reliable" plan to ensure timely deliveries. Key points: AstraZeneca had committed to delivering 180m vaccine doses in the second quarter of this year But it later said it would only be able to deliver 70m …

EU sues AstraZeneca over alleged failure to supply COVID vaccines
3 years, 11 months ago

EU sues AstraZeneca over alleged failure to supply COVID vaccines

Al Jazeera  

Move follows months of rows between Brussels and the British-Swedish company over troubled delivery of vaccine doses. European Commission spokesman Stefan De Keersmaecker said the move to pursue legal action against AstraZeneca was launched last Friday “on the basis of breaches of the advance purchase agreement”. Deliveries dispute Under AstraZeneca’s contract with the EU, the company had committed to making …

EU regulator finds possible link between Johnson & Johnson COVID shot, blood clots
3 years, 11 months ago

EU regulator finds possible link between Johnson & Johnson COVID shot, blood clots

LA Times  

Experts at the agency that regulates drugs for the European Union said Tuesday that they found a “possible link” between the Johnson & Johnson COVID-19 vaccine and very rare blood clots after a small number of cases were reported in the U.S., but they confirmed that the vaccine’s benefits still outweighed the very small risks of recipients developing the unusual …

Pfizer CEO: Third vaccine dose ‘likely’ needed within 12 months
3 years, 11 months ago

Pfizer CEO: Third vaccine dose ‘likely’ needed within 12 months

Al Jazeera  

Researchers currently do not know how long vaccines provide protection against the coronavirus. The head of Pfizer has said that people will “likely” need a third dose of his company’s COVID-19 shot within six to 12 months of vaccination, while defending the relatively higher cost of the jab. “A likely scenario is that there will be likely a need for …

Covid Vaccines: Big Pharma boomerangs against the EU
4 years ago

Covid Vaccines: Big Pharma boomerangs against the EU

NL Times  

To save as many lives as possible, while ensuring pharmaceutical companies secure profits from the race for the vaccine: this is the EU’s "Mission Impossible", faced with a human catastrophe that has already taken more than 2.5 million victims. Economic losses for each week of delay in Covid vaccination Country Hospitality and retail Leisure and recreation Public administration and schools …

EU vaccine chaos as AstraZeneca announces shortfall in shipments
4 years ago

EU vaccine chaos as AstraZeneca announces shortfall in shipments

Daily Mail  

The EU is facing vaccine chaos after AstraZeneca announced a fresh shortfall in planned shipments as five European countries claim others are signing 'secret contracts' to make sure they get extra jabs. The EU is facing vaccine chaos after AstraZeneca announced a fresh shortfall in planned shipments as five European countries claim others are signing 'secret contracts' to make sure …

COVID-19 Vaccines: The EU is at the mercy of Big Pharma
4 years ago

COVID-19 Vaccines: The EU is at the mercy of Big Pharma

NL Times  

Stefano Valentino The vaccine business remains in the hands of the pharmaceutical industry giants. However, in addition to their own factories, pharma giants also rely on smaller, specialized companies located in several European countries. Additionally, the American company Novavax, French firm Valneva and Italy’s Reithera, with whom Brussels has already begun negotiations, will also be added to that list of …

EU gets extra vaccine doses to tackle virus border clusters
4 years ago

EU gets extra vaccine doses to tackle virus border clusters

The Independent  

For free real time breaking news alerts sent straight to your inbox sign up to our breaking news emails Sign up to our free breaking news emails Sign up to our free breaking news emails SIGN UP I would like to be emailed about offers, events and updates from The Independent. Read our privacy policy The European Commission has secured …

February 17 coronavirus news
4 years, 1 month ago

February 17 coronavirus news

CNN  

A nurse prepares a syringe with a dose of the Pfizer-BioNtech Covid-19 vaccine, at a vaccination centre in Quimper, France, on February 16. Fred Tanneau/AFP/Getty Images Pharmaceutical company BioNTech announced Wednesday it had agreed to supply additional 200 million doses of its coronavirus vaccine to the European Commission, which also has the option to request a further 100 million doses. …

WHO slams EU's farcical handling of vaccines row
4 years, 1 month ago

WHO slams EU's farcical handling of vaccines row

Daily Mail  

The World Health Organization has criticised the EU's risible handling of the Covid vaccine debacle, warning that placing export controls on the jabs risked prolonging the pandemic. WHO vice-head Mariangela Simao said that the European Commission's scheme to monitor and, in some cases, bar exports of vaccines produced in EU plants was a 'very worrying' trend. And WHO chief Tedros …

Vaccine war brewing as EU demands Covid jabs produced in UK
4 years, 2 months ago

Vaccine war brewing as EU demands Covid jabs produced in UK

The Independent  

Sign up for the View from Westminster email for expert analysis straight to your inbox Get our free View from Westminster email Get our free View from Westminster email SIGN UP I would like to be emailed about offers, events and updates from The Independent. But AZ insisted that its contracts made clear that the UK had first claim on …

What’s behind the EU-AstraZeneca vaccine row?
4 years, 2 months ago

What’s behind the EU-AstraZeneca vaccine row?

Al Jazeera  

The British-Swedish company has upset the bloc by signalling that it will cut supplies of its COVID shots. The dispute began last week when AstraZeneca, a British-Swedish company, said it would cut supplies to the EU in the first quarter of this year, citing production issues. Following Wednesday’s talks, EU Health Commissioner Stella Kyriakides said there was still a “continued …

EU pressures AstraZeneca to deliver vaccines as promised
4 years, 2 months ago

EU pressures AstraZeneca to deliver vaccines as promised

Associated Press  

BRUSSELS — The European Union lashed out Monday at pharmaceutical company AstraZeneca, accusing it of failing to guarantee delivery of coronavirus vaccines without valid explanation, and threatened to impose tight export controls within days on COVID-19 vaccines made in the bloc. Health Commissioner Stella Kyriakides said the EU, already facing heavy criticism for a slow vaccine rollout around its 27 …

EU vaccine rollout thrown into further disarray as AstraZeneca announces delay
4 years, 2 months ago

EU vaccine rollout thrown into further disarray as AstraZeneca announces delay

The Independent  

For free real time breaking news alerts sent straight to your inbox sign up to our breaking news emails Sign up to our free breaking news emails Sign up to our free breaking news emails SIGN UP I would like to be emailed about offers, events and updates from The Independent. EU leaders had been banking on arrivals of the …

EU doubles COVID-19 vaccines order with Pfizer-BioNTech
4 years, 2 months ago

EU doubles COVID-19 vaccines order with Pfizer-BioNTech

The Hindu  

The European Commission said on Friday it has secured 300 million extra doses of the coronavirus Pfizer-BioNTech vaccine, a move that could ease criticism that the EU’s executive arm has not done enough to procure coronavirus shots for the entire bloc. Speaking during a news conference in Brussels on Friday, European Commission president Ursula von der Leyen said the agreement …

EU rejects criticism for slow vaccine rollout across bloc
4 years, 2 months ago

EU rejects criticism for slow vaccine rollout across bloc

Associated Press  

BRUSSELS — The European Commission defended its coronavirus vaccination strategy Monday amid growing criticism in member states about the slow rollout of COVID-19 shots across the region of 450 million inhabitants. Facing a barrage of questions on vaccines during a news conference, EU Commission spokesman Eric Mamer said the main problem with the deployment of vaccination programs “is an issue …

EU rejects criticism for slow vaccine rollout across bloc
4 years, 2 months ago

EU rejects criticism for slow vaccine rollout across bloc

The Independent  

For free real time breaking news alerts sent straight to your inbox sign up to our breaking news emails Sign up to our free breaking news emails Sign up to our free breaking news emails SIGN UP I would like to be emailed about offers, events and updates from The Independent. Read our privacy policy The European Commission defended its …

EU To Begin Covid-19 Vaccination Drive From Dec 27 Amid Concerns Over Pfizer Shot Reactions
4 years, 3 months ago

EU To Begin Covid-19 Vaccination Drive From Dec 27 Amid Concerns Over Pfizer Shot Reactions

ABP News  

Covid Positive Haryana Minister Anil Vij In Critical Condition, Shifted To Medanta In Gurugram Ursula Von der Leyen, president of the European Commission on Thursday through Twitter confirmed that the Covid-19 vaccination in the European Union will start from December 27, two days after Christmas. According to a statement from the European Medicines Agency, the human medicines body of the …

Covid-19: Pfizer to price vaccine at ’little out-of-pocket expenses’ for Indians
4 years, 3 months ago

Covid-19: Pfizer to price vaccine at ’little out-of-pocket expenses’ for Indians

Live Mint  

New Delhi: Pfizer said that its mRNA vaccine will be priced in a way that will help the Indian government to ensure supply at little or no out-of-pocket expenses for people when the immunisation programme starts. While Pfizer has not declared its pricing for India, the cost in the US is over six times than of the $3 per dose …

How much Pfizer's COVID-19 vaccine will cost? Pharma giant's big statement
4 years, 3 months ago

How much Pfizer's COVID-19 vaccine will cost? Pharma giant's big statement

India TV News  

Pfizer will have differential pricing on its coronavirus vaccine for different countries, as the company aims to make the vaccine available across the world, the global pharma major said on Wednesday. The company's Indian arm has sought emergency use authorisation for the Pfizer/BioNTech vaccine against COVID-19 in the country from the Indian drug regulator. After the UK approval for the …

Covid-19 vaccine to have differential pricing for different countries: Pfizer
4 years, 3 months ago

Covid-19 vaccine to have differential pricing for different countries: Pfizer

Live Mint  

Global pharma major Pfizer has said it will have differential pricing on its COVID-19 vaccine for different countries, as the company aims to make the vaccine available across the world. The company's Indian arm has sought emergency use authorisation for the Pfizer/BioNTech vaccine against COVID-19 in the country from the Indian drug regulator. After the UK approval for the vaccine, …

Covid vaccine: Pfizer request emergency use authorisation from European regulator
4 years, 3 months ago

Covid vaccine: Pfizer request emergency use authorisation from European regulator

The Independent  

Sign up for our free Health Check email to receive exclusive analysis on the week in health Get our free Health Check email Get our free Health Check email SIGN UP I would like to be emailed about offers, events and updates from The Independent. Read our privacy policy Pfizer and its German partner BioNTech have asked the European drugs …

Moderna will charge Rs 1,900-2,800 for coronavirus vaccine, says CEO
4 years, 4 months ago

Moderna will charge Rs 1,900-2,800 for coronavirus vaccine, says CEO

India Today  

Moderna will charge governments between $25 and $37 per dose of its Covid-19 vaccine candidate, depending on the amount ordered, Chief Executive Stephane Bancel told German weekly Welt am Sonntag. On Monday, an EU official involved in the talks said the European Commission wanted to reach a deal with Moderna for the supply of millions of doses of its vaccine …

Pfizer-BioNTech vaccine: EU to buy up to 300 million doses
4 years, 4 months ago

Pfizer-BioNTech vaccine: EU to buy up to 300 million doses

Live Mint  

The European Commission will sign a deal to secure up to 300 million doses of the experimental coronavirus vaccine developed by BioNTech and Pfizer. Ursula von der Leyen, the president of the EU's executive arm, said the commission will authorize the deal on Wednesday after “working tirelessly to secure doses of potential vaccines” in recent months. “This is the most …

EU agrees to buy 300 million doses of the Pfizer/BioNTech Covid-19 vaccine
4 years, 4 months ago

EU agrees to buy 300 million doses of the Pfizer/BioNTech Covid-19 vaccine

CNN  

Berlin CNN — The European Union has formally authorized a fourth contract with the US pharmaceutical giant Pfizer and their German lab partner BioNTech to procure up to 300 million doses of their candidate coronavirus vaccine, should it be proven to be safe and effective against the virus. “In the wake of Monday’s promising announcement by BioNTech and Pfizer on …

Europe to pay less than US for Pfizer COVID-19 vaccine
4 years, 4 months ago

Europe to pay less than US for Pfizer COVID-19 vaccine

Al Jazeera  

The EU has struck a deal to initially pay less for Pfizer’s vaccine candidate, an official source tells Reuters News Agency. The European Union has struck a deal to initially pay less for Pfizer’s COVID-19 vaccine candidate than the United States, an EU official told Reuters News Agency as the bloc announced on Wednesday it had secured an agreement for …

Activists urge ’Big Pharma’ to be transparent on COVID-19 vaccine costs
4 years, 5 months ago

Activists urge ’Big Pharma’ to be transparent on COVID-19 vaccine costs

Live Mint  

Activists called on pharmaceutical companies on Thursday to be transparent about the costs and terms of providing COVID-19 vaccines, saying they must be available and affordable for all. French drugmaker Sanofi and Britain's GlaxoSmithKline said on Wednesday they would supply 200 million doses of their COVID-19 candidate vaccine to the global COVAX vaccine facility backed by the World Health Organization …

EU agrees to buy 200 million doses of Leiden coronavirus vaccine
4 years, 5 months ago

EU agrees to buy 200 million doses of Leiden coronavirus vaccine

Dutch News  

The European Commission has signed a contract with Leiden-based pharmaceuticals company Janssen for the supply of 200 million doses of its coronavirus vaccine. Of those, at least 7.8 million doses would be allocated to the Dutch market, as soon as the vaccine has approval, health minister Hugo de Jonge told MPs on Thursday. The vaccine, if successful, is likely to …

Covid vaccine: AstraZeneca gets partial immunity against claim over side-effects
4 years, 6 months ago

Covid vaccine: AstraZeneca gets partial immunity against claim over side-effects

Live Mint  

European governments will pay claims above an agreed limit against AstraZeneca over side-effects from its potential COVID-19 vaccine, under different terms to a deal struck with Sanofi, an EU official told Reuters. Under the deal, AstraZeneca would only pay legal costs up to a certain threshold, the official said, declining to elaborate on how the costs would be shared with …

EU enters final talks for BioNTech-Pfizer vaccine
4 years, 6 months ago

EU enters final talks for BioNTech-Pfizer vaccine

Live Mint  

The European Commission said on Wednesday it had entered final stage talks with BioNTech-Pfizer to purchase up to 300 million doses of a potential vaccine against COVID-19. The envisaged contract with Germany's BioNTech and U.S.-based Pfizer would lead to an initial purchase of 200 million doses, with an option to buy a further 100 million, the Commission said after the …

EU offers 400 mln euros to WHO-led COVID-19 vaccine initiative
4 years, 6 months ago

EU offers 400 mln euros to WHO-led COVID-19 vaccine initiative

Live Mint  

The European Commission said on Monday it would contribute 400 million euros to an initiative led by the World Health Organization to buy COVID-19 vaccines. The EU Commission is negotiating advance purchases of COVID-19 vaccines with several drugmakers on behalf of the 27 EU states and has said in past weeks EU governments cannot buy vaccines through parallel procurement schemes. …

US in $1.5bn deal with Moderna for potential coronavirus vaccine
4 years, 7 months ago

US in $1.5bn deal with Moderna for potential coronavirus vaccine

Al Jazeera  

The deal is the latest between the US and drugmakers to secure hundreds of millions of doses of likely vaccines. The United States has entered an agreement with drugmaker Moderna Inc to acquire 100 million doses of its potential coronavirus vaccine for approximately $1.5bn, the company and White House said. And earlier this month, the federal government also reached a …

US to pay $1 bn for 100 mn doses of J&J’s potential coronavirus vaccine
4 years, 7 months ago

US to pay $1 bn for 100 mn doses of J&J’s potential coronavirus vaccine

Live Mint  

The United States government will pay Johnson & Johnson over $1 billion for 100 million doses of its potential coronavirus vaccine, as it stocks up on vaccine and drugs in an attempt to tame the pandemic. The latest contract is priced at roughly $10 per vaccine dose produced by J&J, or around $14.50 per dose, including a previous $456 million …

US Govt to Pay $1 Billion for 100 Million Doses of J&J's Coronavirus Vaccine Candidate
4 years, 7 months ago

US Govt to Pay $1 Billion for 100 Million Doses of J&J's Coronavirus Vaccine Candidate

News 18  

The United States government will pay Johnson & Johnson over $1 billion for 100 million doses of its potential coronavirus vaccine, as it stocks up on vaccine and drugs in an attempt to tame the pandemic. The latest contract is priced at roughly $10 per vaccine dose produced by J&J, or $20 per dose, including a second $1 billion from …

Preparing for Ahead: Sanofi in Talks With EU for Supply of 300 Million Doses of Experimental Covid-19 Vaccine
4 years, 7 months ago

Preparing for Ahead: Sanofi in Talks With EU for Supply of 300 Million Doses of Experimental Covid-19 Vaccine

News 18  

pSanofi SA and GlaxoSmithKline Plc on Friday said they are in advanced discussions to supply up to 300 million doses of an experimental COVID-19 vaccine for the 27-country European Union. “The envisaged contract with Sanofi would provide for an option for all EU Member States to purchase the vaccine,” the Commission said in a statement. “It is envisaged that, once …

Britain Signs Deal for up to 60 Million Doses of Possible Covid-19 Vaccine Being Developed by Sanofi/GSK
4 years, 8 months ago

Britain Signs Deal for up to 60 Million Doses of Possible Covid-19 Vaccine Being Developed by Sanofi/GSK

News 18  

Britain has signed a deal for up to 60 million doses of a possible COVID-19 vaccine being developed by Sanofi and GlaxoSmithKline, it said on Wednesday, its fourth such arrangement as the race to tame the pandemic heats up. It is Sanofi and GSK's first deal to supply their experimental COVID-19 vaccine to a country, and British ministers have stressed …

At about ₹1,500 per shot of covid vaccine, US sets global pricing benchmark
4 years, 8 months ago

At about ₹1,500 per shot of covid vaccine, US sets global pricing benchmark

Live Mint  

The US government has set a benchmark for COVID-19 vaccine pricing in a $2 billion deal announced on Wednesday with Pfizer Inc and German biotech BioNTech SE that will likely pressure other manufacturers to set similar prices, industry analysts told Reuters. The deal, which is contingent on an approvable product, secures enough vaccine to inoculate 50 million Americans for about …

Discover Related